Hongshan (红杉中国) is a venture capital investor focused on discovering and nurturing industry-leading companies. The firm operates in China and covers investments across technology-driven sectors, with emphasis on long-term value creation and company-building. Its portfolio and public-facing content highlight focus on healthcare, AI, robotics, consumer brands, and other high-growth sectors within the Chinese market.
Shanghai Start-Up Launches to Develop Trispecific Antibodies
China’s Moonshot Releases a New Open-Source Model Kimi K2.5 and a Coding Agent
X Square Robot Secures $140 Million in Series A++ Funding
How Busy Ming Rose Behind a Low-Profile but Resolute Founder
China’s Simplexity Robotics Raises $289M USD to Develop and Deploy Embodied AI Tech
VC RETURNS REVEALED: Recent Thrive & Notable Funds in a League of Their Own at UTIMCO